About ONOCOR
ONOCOR is a Healthcare company based in Philadelphia (United States) founded in 2022. ŌNŌ creates medical devices for percutaneous heart implant retrieval and structural interventions. It operates on a B2B model. ONOCOR offers products and services including Transcatheter Retrieval System. Its focus areas include Medical Devices, Interventional, Catheter-Based and Cardiovascular. Its competitors include Atraverse Medical, ValCor Cath and Helios Cardio; 2 of its 3 listed competitors have raised funding.
Company details
ŌNŌ focuses on developing transcatheter retrieval systems that enable the safe, percutaneous removal of misplaced heart devices, reducing the need for invasive surgery. The company advances catheter-based interventions for structural heart disease, providing tools that minimize risks for patients and operators. Based in the United States, ŌNŌ collaborates with distributors to make these technologies available, supporting growth in less invasive treatments for conditions like atrial fibrillation.
- Headquarters Philadelphia, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website onocorvascular.com
- Social X Instagram
Products & Services of ONOCOR
ONOCOR offers a comprehensive portfolio of products and services, including Transcatheter Retrieval System.
System for percutaneous removal of heart implants to avoid surgery.
Competitors of ONOCOR
ONOCOR has 3 listed competitors in our database, 2 of them funded. They include Atraverse Medical, ValCor Cath and Helios Cardio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atraversemedical.com | 2022 | Chicago, United States | $61.9M | Next-generation tools for left-heart access are developed for cardiac treatments. | ||
| 2023 | Toledo, United States | $1.07M | Medical devices for cardiac surgeries are developed. | |||
| helioscardio.com | 2019 | Weston, United States | Develops biologic matrices for cardiac repair and regeneration of heart conditions. |
Detailed competitors of ONOCOR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ONOCOR
The website of ONOCOR (onocorvascular.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 34.3% vs previous month
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as ONOCOR (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Onocor
Complete news archive for ONOCOR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ONOCOR
ONOCOR was founded in 2022.
ONOCOR is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
ŌNŌ focuses on developing transcatheter retrieval systems that enable the safe, percutaneous removal of misplaced heart devices, reducing the need for invasive surgery. The company advances catheter-based interventions for structural heart disease, providing tools that minimize risks for patients and operators. Based in the United States, ŌNŌ collaborates with distributors to make these technologies available, supporting growth in less invasive treatments for conditions like atrial fibrillation.
ONOCOR's top competitors include Atraverse Medical, ValCor Cath and Helios Cardio.
ONOCOR offers Transcatheter Retrieval System.